Gastrointestinal Cancer News

In partnership with DDW, Healio Gastroenterology brings you physician research from the investigators themselves. Here, Fabio Bagante, MD, discusses a new nomogram for neuroendocrine liver metastasis.

SAN DIEGO — Experts at a colorectal cancer symposium here at Digestive Disease Week 2016 discussed a number of topics, including barriers to screening, when to start and stop screening and novel approaches and technologies.

SAN DIEGO —  Non-white patients with hepatocellular carcinoma were less likely to undergo curative therapy and more likely to experience therapeutic delays than white patients, according to findings presented at Digestive Disease Week 2016.

The adoption of healthy lifestyle practices may prevent a large proportion of cancers and reduce cancer mortality in the United States, according to results of a prospective cohort study.

Oral apatinib conferred a small but statistically significant OS and PFS benefit among patients with gastric cancer who failed two or more lines of chemotherapy, according to results of a randomized phase 3 trial.

Patients treated in phase 1 trials designed with a biomarker-based approach for treatment selection demonstrated higher response rates and longer PFS, according to results of a meta-analysis scheduled for presentation at the ASCO Annual Meeting.

Non-Hispanic black patients with young-onset colorectal cancer experienced poorer survival outcomes than their white counterparts, according to results of a SEER analysis.

The introduction of palliative care early after a diagnosis of incurable cancer improved the quality of life of the patients’ family caregivers, according to the results of a randomized trial scheduled for presentation at the ASCO Annual Meeting.

Patients with metastatic colorectal cancer who had a right-sided primary tumor achieved prolonged OS and PFS compared with patients who had a left-sided primary tumor, according to results of a retrospective analysis scheduled for presentation at the ASCO Annual Meeting.

The U.S. House Energy Subcommittee on Health today held a hearing to offer doctor and patient perspectives on planned changes to the Medicare Part B drug reimbursement model.